However, recent findings suggest that the likelihood of experiencing a local recurrence in breast cancer differs depending on the breast cancer subtype, as characterized by estrogen receptor (ER), progesterone receptor (PR), and HER2/neu status. This evidence concerns the gene ERBB2 and breast cancer.